Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

The Addition of Bevacizumab to Standard Therapy with R-CHOP in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma Is Associated with an Increased Rate of Cardiac Adverse Events: Final Analysis of Safety and Efficacy Outcomes From the Placebo-Controlled Phase 3 MAIN Study

John F. Seymour, MBBS FRACP, Michael Pfreundshuh, MD, B. Coiffier, MD, Marek Trneny, MD, PhD, Laurie H. Sehn, MD, Eva Csinady

Blood (2012) 120 (21): 58.

https://doi.org/10.1182/blood.V120.21.58.58

Published: 2012

Journal Articles

Early Results of a Phase Ib/II Dose-Escalation Trial of Romidepsin in Association with CHOP in Patients with Peripheral T-Cell Lymphomas (PTCL)

Jehan Dupuis, MD, Rene-Olivier Casasnovas, Franck Morschhauser, Herve Ghesquieres, MD, PhD, Catherine Thieblemont, MD, Vincent Ribrag, MD, Herve Tilly, B. Coiffier, MD

Blood (2011) 118 (21): 2673.

https://doi.org/10.1182/blood.V118.21.2673.2673

Published: 2011

Journal Articles

R-CHOP Versus R-FC Followed by Maintenance with Rituximab Versus Interferon-Alfa: Outcome of the First Randomized Trial for Elderly Patients with Mantle Cell Lymphoma

J.C. Kluin-Nelemans, E. Hoster, J. Walewski, MD, S. Stilgenbauer, M.D., C. H. Geisler, C. Gisselbrecht, MD, U. Vehling-Kaiser, MD, J. K. Doorduijn, MD, M. Trneny, MD, B. Coiffier, MD, R. Forstpointner, MD, H. Tilly, MD, L. Kanz, MD, M. Szymczyk, MD, O. Hermine, MD, PhD, W. Klapper, MD, W. Hiddemann, MD, M. Unterhalt, PhD, M. H. Dreyling, MD

Blood (2011) 118 (21): 439.

https://doi.org/10.1182/blood.V118.21.439.439

Published: 2011

Journal Articles

Long Term Follow-up of the GELF86 French and Belgian Trials: Complete Remission after First Line Treatment with Conventional Chemotherapy in Newly Diagnosed Follicular Lymphoma Patients Correlates with Prolonged Overall Survival Compared with Partial Remission

E. Bachy, P. Brice, M. Fournier, H. Tilly, C. Haioun, N. Brousse, S. Le Gouil, A. Bosly, B. Coiffier, C. Gisselbrecht, P. Solal-Celigny, G. Salles

Blood (2008) 112 (11): 2590.

https://doi.org/10.1182/blood.V112.11.2590.2590

Published: 2008

Journal Articles

Safety of Prophylactic Use of Darbepoetin Alfa in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Treated with R-CHOP 14 or R-CHOP21: Preliminary Results of the LNH03-6B Randomized GELA Study.

R. Delarue, N. Mounier, C. Haioun, B. Coiffier, C. Gisselbrecht, H. Ghesquieres, P. Lederlin, M. Blanc, C. Recher, O. Hermine, F. Reyes, H. Tilly, A. Bosly

Blood (2006) 108 (11): 2436.

https://doi.org/10.1182/blood.V108.11.2436.2436

Published: 2006

Journal Articles

Rituximab/Chemotherapy Induction Treatment Followed by High-Dose Therapy and Autologous Transplantation in Patients with Mantle Cell Lymphoma.

C. Thieblemont, D. Antal, L. Lacotte-Thierry, V. Delwail, F. Bouafia, S. Tartas, A.S. Michallet, D. Espinouse, C. Giraud, G. Salles, F. Guilhot, B. Coiffier

Blood (2004) 104 (11): 1389.

https://doi.org/10.1182/blood.V104.11.1389.1389

Published: 2004

Journal Articles

Glutathione-S-Transferase π Expression Helps for Differential Diagnosis between Mantle Cell Lymphoma and Marginal Zone Lymphoma with t(11;14).

D. Rolland, S. Gazzo, P. Felman, E. Callet-Bauchu, A. Traverse-Glehen, L. Baseggio, A. Paret, F. Chapuis, G. Salles, B. Coiffier, F. Berger, C. Thieblemont

Blood (2004) 104 (11): 1364.

https://doi.org/10.1182/blood.V104.11.1364.1364

Published: 2004

Journal Articles

Is Conventional Allogeneic Haematopoietic Stem Cell Transplantation (HSCT) an Optimal Long-Term Strategy for Non Hodgkin Lymphomas: A Retrospective Study from 1987 to 2004.

Anne-Sophie A.S. Michallet, MD, Sophie S. Tartas, MD, Quoc-Hung Q.H. Le, MD, Franck F. Nicolini, MD PhD, Nicole N. Raus, Anne A. Thiebaut, MD, Xavier X. Thomas, MD, Francoise F. Berger, MD PhD, Pascale P. Felman, MD phD, Gilles G. Salles, MD PhD, Bertrand B. Coiffier, MD PhD, Mauricette M. Michallet, MD PhD

Blood (2004) 104 (11): 3328.

https://doi.org/10.1182/blood.V104.11.3328.3328

Published: 2004

Journal Articles

Gene Expression Profiling Analysis in Splenic Marginal Zone Lymphoma Allows To Predict Survival and Histological Transformation.

C. Thieblemont, B. Ballester, V. Nasser, S. Gazzo, G. Doucet, P. Felman, E. Callet-Bauchu, F. Berger, L. Loi, G. Salles, D. Birnbaum, B. Coiffier, R. Houlgatte

Blood (2004) 104 (11): 1125.

https://doi.org/10.1182/blood.V104.11.1125.1125

Published: 2004

Journal Articles

Rituximab (Anti-CD20 Monoclonal Antibody) for the Treatment of Patients With Relapsing or Refractory Aggressive Lymphoma: A Multicenter Phase II Study

B. Coiffier, C. Haioun, N. Ketterer, A. Engert, H. Tilly, D. Ma, P. Johnson, A. Lister, M. Feuring- Buske, J.A. Radford, R. Capdeville, V. Diehl, F. Reyes

Blood (1998) 92 (6): 1927–1932.

https://doi.org/10.1182/blood.V92.6.1927

Published: 1998

Journal Articles

Lymphoma classification--the gap between biology and clinical management is closing

W Hiddemann, DL Longo, B Coiffier, RI Fisher, F Cabanillas, F Cavalli, LM Nadler, VT De Vita, TA Lister, JO Armitage

Blood (1996) 88 (11): 4085–4089.

https://doi.org/10.1182/blood.V88.11.4085.4085

Published: 1996

Journal Articles

Intensive therapy with peripheral blood progenitor cell transplantation in 60 patients with poor-prognosis follicular lymphoma

Y Bastion, P Brice, C Haioun, A Sonet, G Salles, JP Marolleau, D Espinouse, F Reyes, C Gisselbrecht, B Coiffier

Blood (1995) 86 (8): 3257–3262.

https://doi.org/10.1182/blood.V86.8.3257.3257

Published: 1995

Journal Articles

Nonfollicular small B-cell lymphomas: a heterogeneous group of patients with distinct clinical features and outcome

F Berger, P Felman, A Sonet, G Salles, Y Bastion, PA Bryon, B Coiffier

Blood (1994) 83 (10): 2829–2835.

https://doi.org/10.1182/blood.V83.10.2829.2829

Published: 1994

Journal Articles

Interleukin-2 treatment in lymphoma: a phase II multicenter study [see comments]

C Gisselbrecht, D Maraninchi, JL Pico, N Milpied, B Coiffier, M Divine, P Tiberghien, A Bosly, H Tilly, O Boulat

Blood (1994) 83 (8): 2081–2085.

https://doi.org/10.1182/blood.V83.8.2081.2081

Published: 1994

Journal Articles

Detection of the chromosomal translocation t(11;14) by polymerase chain reaction in mantle cell lymphomas

R Rimokh, F Berger, G Delsol, I Digonnet, JP Rouault, JD Tigaud, M Gadoux, B Coiffier, PA Bryon, JP Magaud

Blood (1994) 83 (7): 1871–1875.

https://doi.org/10.1182/blood.V83.7.1871.1871

Published: 1994

Journal Articles

Rearrangement and overexpression of the BCL-1/PRAD-1 gene in intermediate lymphocytic lymphomas and in t(11q13)-bearing leukemias

R Rimokh, F Berger, G Delsol, C Charrin, MF Bertheas, M Ffrench, M Garoscio, P Felman, B Coiffier, PA Bryon

Blood (1993) 81 (11): 3063–3067.

https://doi.org/10.1182/blood.V81.11.3063.3063

Published: 1993

Journal Articles

Recombinant human granulocyte-macrophage colony-stimulating factor after high-dose chemotherapy and autologous bone marrow transplantation with unpurged and purged marrow in non-Hodgkin's lymphoma: a double- blind placebo-controlled trial

NC Gorin, B Coiffier, M Hayat, L Fouillard, M Kuentz, M Flesch, P Colombat, P Boivin, S Slavin, T Philip

Blood (1992) 80 (5): 1149–1157.

https://doi.org/10.1182/blood.V80.5.1149.1149

Published: 1992

Journal Articles

Prognosis of aggressive lymphomas: a study of five prognostic models with patients included in the LNH-84 regimen

B Coiffier, E Lepage

Blood (1989) 74 (2): 558–564.

https://doi.org/10.1182/blood.V74.2.558.558

Published: 1989

Journal Articles

Intensive chemotherapy in aggressive lymphomas: updated results of LNH- 80 protocol and prognostic factors affecting response and survival

B Coiffier, PA Bryon, M Ffrench, M Blanc, C Sebban, F Berger, JJ Viala

Blood (1987) 70 (5): 1394–1399.

https://doi.org/10.1182/blood.V70.5.1394.1394

Published: 1987

NARROW

The Addition of Bevacizumab to Standard Therapy with R-CHOP in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma Is Associated with an Increased Rate of Cardiac Adverse Events: Final Analysis of Safety and Efficacy Outcomes From the Placebo-Controlled Phase 3 MAIN Study

Early Results of a Phase Ib/II Dose-Escalation Trial of Romidepsin in Association with CHOP in Patients with Peripheral T-Cell Lymphomas (PTCL)

R-CHOP Versus R-FC Followed by Maintenance with Rituximab Versus Interferon-Alfa: Outcome of the First Randomized Trial for Elderly Patients with Mantle Cell Lymphoma

Long Term Follow-up of the GELF86 French and Belgian Trials: Complete Remission after First Line Treatment with Conventional Chemotherapy in Newly Diagnosed Follicular Lymphoma Patients Correlates with Prolonged Overall Survival Compared with Partial Remission

Safety of Prophylactic Use of Darbepoetin Alfa in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Treated with R-CHOP 14 or R-CHOP21: Preliminary Results of the LNH03-6B Randomized GELA Study.

Rituximab/Chemotherapy Induction Treatment Followed by High-Dose Therapy and Autologous Transplantation in Patients with Mantle Cell Lymphoma.

Glutathione-S-Transferase π Expression Helps for Differential Diagnosis between Mantle Cell Lymphoma and Marginal Zone Lymphoma with t(11;14).

Is Conventional Allogeneic Haematopoietic Stem Cell Transplantation (HSCT) an Optimal Long-Term Strategy for Non Hodgkin Lymphomas: A Retrospective Study from 1987 to 2004.

Gene Expression Profiling Analysis in Splenic Marginal Zone Lymphoma Allows To Predict Survival and Histological Transformation.

Rituximab (Anti-CD20 Monoclonal Antibody) for the Treatment of Patients With Relapsing or Refractory Aggressive Lymphoma: A Multicenter Phase II Study

Lymphoma classification--the gap between biology and clinical management is closing

Intensive therapy with peripheral blood progenitor cell transplantation in 60 patients with poor-prognosis follicular lymphoma

Nonfollicular small B-cell lymphomas: a heterogeneous group of patients with distinct clinical features and outcome

Interleukin-2 treatment in lymphoma: a phase II multicenter study [see comments]

Detection of the chromosomal translocation t(11;14) by polymerase chain reaction in mantle cell lymphomas

Rearrangement and overexpression of the BCL-1/PRAD-1 gene in intermediate lymphocytic lymphomas and in t(11q13)-bearing leukemias

Recombinant human granulocyte-macrophage colony-stimulating factor after high-dose chemotherapy and autologous bone marrow transplantation with unpurged and purged marrow in non-Hodgkin's lymphoma: a double- blind placebo-controlled trial

Prognosis of aggressive lymphomas: a study of five prognostic models with patients included in the LNH-84 regimen

Intensive chemotherapy in aggressive lymphomas: updated results of LNH- 80 protocol and prognostic factors affecting response and survival

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only